Skip to main content
. 2017 Jan 16;8(8):12983–13002. doi: 10.18632/oncotarget.14677

Figure 3. Kaplan-Meier curves for patients with HCC.

Figure 3

(A) OS and RR of patients according to the different expression levels of PHD3 in TAMs. (B) OS and RR of patients according to the different expression levels of FIH in TAMs. (C) early and late recurrence of patients according to the different expression levels of PHD3 in TAMs. (D) early and late recurrence of patients according to the different expression levels of FIH in TAMs. (E) OS and RR of patients according to the different expression levels of PHD3 and FIH in TAMs. The log-rank test was used.